BACKGROUND: Mathematical models based on kinetics of HIV-1 plasma viremia after initiation of combination antiretroviral therapy (cART) inferred HIV-infected cells to decay exponentially with constant rates correlated to their strength of virus production. To further define in vivo decay kinetics of HIV-1 infected cells experimentally, we assessed infected cell-classes of distinct viral transcriptional activity in peripheral blood mononuclear cells (PBMC) of five patients during 1 year after initiation of cART RESULTS: In a novel analytical approach patient-matched PCR for unspliced and multiply spliced viral RNAs was combined with limiting dilution analysis at the single cell level. This revealed that HIV-RNA+ PBMC can be stratified into f...
Early intervention resulted in profound depletion of PBMC expressing HIV-1 RNA. This is contrary to ...
Patients in whom virologic suppression is achieved with highly active antiretroviral therapy (HAART)...
Ahmad R Sedaghat is with Johns Hopkins University School of Medicine, Janet D Siliciano is with John...
HIV-1-infected cells in peripheral blood can be grouped into different transcriptional subclasses. Q...
<div><p>HIV-1-infected cells in peripheral blood can be grouped into different transcriptional subcl...
To characterize newly arising replication of human immunodeficiency virus (HIV) type 1 in vivo at th...
To characterize newly arising replication of human immunodeficiency virus (HIV) type 1 in vivo at th...
To characterize newly arising replication of human immunodeficiency virus (HIV) type 1 in vivo at th...
HIV type 1 (HIV-1) persists within resting CD4 + T cells despite anti-retroviral therapy (ART). To b...
HIV type 1 (HIV-1) persists within resting CD4+ T cells despite antiretroviral therapy (ART). To bet...
In persons living with HIV-1 (PLWH) who start antiretroviral therapy (ART), plasma virus decays in a...
BackgroundAlthough combination antiretroviral therapy (cART) initiated in the acute phase of HIV-1 i...
Although combination antiretroviral therapy (cART) initiated in the acute phase of HIV-1 infection m...
The kinetics of HIV-1 decay under treatment depends on the class of antiretrovirals used. Mathematic...
Treatment of HIV-1 infection with combination antiretroviral therapy (ART) reduces plasma HIV-1 RNA ...
Early intervention resulted in profound depletion of PBMC expressing HIV-1 RNA. This is contrary to ...
Patients in whom virologic suppression is achieved with highly active antiretroviral therapy (HAART)...
Ahmad R Sedaghat is with Johns Hopkins University School of Medicine, Janet D Siliciano is with John...
HIV-1-infected cells in peripheral blood can be grouped into different transcriptional subclasses. Q...
<div><p>HIV-1-infected cells in peripheral blood can be grouped into different transcriptional subcl...
To characterize newly arising replication of human immunodeficiency virus (HIV) type 1 in vivo at th...
To characterize newly arising replication of human immunodeficiency virus (HIV) type 1 in vivo at th...
To characterize newly arising replication of human immunodeficiency virus (HIV) type 1 in vivo at th...
HIV type 1 (HIV-1) persists within resting CD4 + T cells despite anti-retroviral therapy (ART). To b...
HIV type 1 (HIV-1) persists within resting CD4+ T cells despite antiretroviral therapy (ART). To bet...
In persons living with HIV-1 (PLWH) who start antiretroviral therapy (ART), plasma virus decays in a...
BackgroundAlthough combination antiretroviral therapy (cART) initiated in the acute phase of HIV-1 i...
Although combination antiretroviral therapy (cART) initiated in the acute phase of HIV-1 infection m...
The kinetics of HIV-1 decay under treatment depends on the class of antiretrovirals used. Mathematic...
Treatment of HIV-1 infection with combination antiretroviral therapy (ART) reduces plasma HIV-1 RNA ...
Early intervention resulted in profound depletion of PBMC expressing HIV-1 RNA. This is contrary to ...
Patients in whom virologic suppression is achieved with highly active antiretroviral therapy (HAART)...
Ahmad R Sedaghat is with Johns Hopkins University School of Medicine, Janet D Siliciano is with John...